Literature DB >> 22462666

Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model.

Eroboghene E Ubogu1, Nejla Yosef, Robin H Xia, Kazim A Sheikh.   

Abstract

The objective of this study was to define the behavioral, electrophysiological, and morphological characteristics of spontaneous autoimmune peripheral polyneuropathy (SAPP) in female B7-2 deficient non-obese diabetic (NOD) mice. A cohort of 77 female B7-2 deficient and 31 wild-type control NOD mice were studied from 18 to 40 weeks of age. At pre-defined time points, the dorsal caudal tail and sciatic motor nerve conduction studies (MNCS) were performed. Sciatic nerves were harvested for morphological evaluation. SAPP mice showed slowly progressive severe weakness in hind and forelimbs without significant recovery after 30 weeks of age. MNCS showed progressive reduction in mean compound motor action potential amplitudes and conduction velocities, and increase in mean total waveform duration from 24 to 27 weeks of age, peaking between 32 and 35 weeks of age. Toluidine blue-stained, semi-thin plastic-embedded sections demonstrated focal demyelination associated with mononuclear cell infiltration early in the disease course, with progressively diffuse demyelination and axonal loss associated with more intense mononuclear infiltration at peak severity. Immunohistochemistry confirmed macrophage-predominant inflammation. This study verifies SAPP as a progressive, unremitting chronic inflammatory demyelinating polyneuropathy with axonal loss.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462666      PMCID: PMC5792059          DOI: 10.1111/j.1529-8027.2012.00375.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  16 in total

Review 1.  The role of macrophages in immune-mediated damage to the peripheral nervous system.

Authors:  R Kiefer; B C Kieseier; G Stoll; H P Hartung
Journal:  Prog Neurobiol       Date:  2001-06       Impact factor: 11.685

2.  Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy.

Authors:  M Nagamatsu; S Terao; K Misu; M Li; N Hattori; M Ichimura; M Sakai; H Yamamoto; H Watanabe; S Riku; E Ikeda; J Hata; M Oda; M Satake; N Nakamura; S Matsuya; Y Hashizume; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

3.  Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP).

Authors:  N Rizzuto; M Morbin; T Cavallaro; S Ferrari; M Fallahi; S Galiazzo Rizzuto
Journal:  Acta Neuropathol       Date:  1998-12       Impact factor: 17.088

4.  Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data.

Authors:  Robin H Xia; Nejla Yosef; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2010-06       Impact factor: 3.217

5.  Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy.

Authors:  C Bouchard; C Lacroix; V Planté; D Adams; F Chedru; J M Guglielmi; G Said
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

Review 6.  Immune mechanisms in chronic inflammatory demyelinating neuropathy.

Authors:  Bernd C Kieseier; Marinos C Dalakas; Hans-Peter Hartung
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

Review 7.  From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve.

Authors:  Gerd Meyer zu Hörste; Hans-Peter Hartung; Bernd C Kieseier
Journal:  Nat Clin Pract Neurol       Date:  2007-04

8.  Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.

Authors:  Robin H Xia; Nejla Yosef; Eroboghene E Ubogu
Journal:  J Neuroimmunol       Date:  2010-01-19       Impact factor: 3.478

9.  Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.

Authors:  B Salomon; L Rhee; H Bour-Jordan; H Hsin; A Montag; B Soliven; J Arcella; A M Girvin; J Padilla; S D Miller; J A Bluestone
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

10.  A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy.

Authors:  Cédric Louvet; Beniwende G Kabre; Dan W Davini; Nicolas Martinier; Maureen A Su; Jason J DeVoss; Wendy L Rosenthal; Mark S Anderson; Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2009-02-16       Impact factor: 14.307

View more
  19 in total

1.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Chaoling Dong; Kelsey M Greathouse; Rebecca L Beacham; Steven P Palladino; E Scott Helton; Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2017-02-16       Impact factor: 5.330

3.  VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy.

Authors:  Mehmet E Yalvac; William David Arnold; Syed-Rehan A Hussain; Cilwyn Braganza; Kimberly M Shontz; Kelly Reed Clark; Christopher M Walker; Eroboghene E Ubogu; Jerry R Mendell; Zarife Sahenk
Journal:  Mol Ther       Date:  2014-04-25       Impact factor: 11.454

4.  In situ molecular characterization of endoneurial microvessels that form the blood-nerve barrier in normal human adult peripheral nerves.

Authors:  Xuan Ouyang; Chaoling Dong; Eroboghene E Ubogu
Journal:  J Peripher Nerv Syst       Date:  2019-06-04       Impact factor: 3.494

Review 5.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

6.  Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy.

Authors:  Chaoling Dong; E Scott Helton; Ping Zhou; Xuan Ouyang; Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-09-05

7.  The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.

Authors:  Chaoling Dong; Steven P Palladino; Eric Scott Helton; Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2016-07-26       Impact factor: 17.088

Review 8.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 9.  Biology of the human blood-nerve barrier in health and disease.

Authors:  Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2020-03-03       Impact factor: 5.330

10.  Translational strategies in peripheral neuroinflammation and neurovascular repair.

Authors:  Eroboghene E Ubogu
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.